Market Research Logo

Tinnitus - Pipeline Review, H2 2015

Tinnitus - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Tinnitus - Pipeline Review, H2 2015’, provides an overview of the Tinnitus’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Tinnitus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Tinnitus and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Tinnitus
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Tinnitus and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Tinnitus products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Tinnitus pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Tinnitus
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Tinnitus pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Global Markets Direct Report Coverage
Tinnitus Overview
Therapeutics Development
Pipeline Products for Tinnitus - Overview
Pipeline Products for Tinnitus - Comparative Analysis
Tinnitus - Therapeutics under Development by Companies
Tinnitus - Therapeutics under Investigation by Universities/Institutes
Tinnitus - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Unknown Stage Products
Tinnitus - Products under Development by Companies
Tinnitus - Products under Investigation by Universities/Institutes
Tinnitus - Companies Involved in Therapeutics Development
AudioCure Pharma GmbH
Auris Medical Holding AG
Flexion Therapeutics, Inc.
Knopp Biosciences LLC
Merz Pharma GmbH & Co. KgaA
Otonomy, Inc.
SciFluor Life Sciences, LLC
Sound Pharmaceuticals, Inc.
Synphora AB
Tinnitus - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
acamprosate calcium - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AM-102 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AUT-00063 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AUT-3 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Drug to Activate KCNQ for Tinnitus - Drug Profile
Product Description
Mechanism of Action
R&D Progress
esketamine hydrochloride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
gacyclidine SR - Drug Profile
Product Description
Mechanism of Action
R&D Progress
latanoprost - Drug Profile
Product Description
Mechanism of Action
R&D Progress
neramexane mesylate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SF-0034 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Tinnitus - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Activate Kv7 for Neuropathic Pain, Epilepsy and Tinnitus - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules To Inhibit TNF-Alpha for Tinnitus - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SPI-1005 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SPI-3005 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Tinnitus - Recent Pipeline Updates
Tinnitus - Dormant Projects
Tinnitus - Product Development Milestones
Featured News & Press Releases
Jul 02, 2015: Auris Medical Holding Provides Update on U.S. Intellectual Property Portfolio
Jun 19, 2015: SciFluor Life Sciences Patented Compound SF0034 Highlighted in Research Published in The Journal of Neuroscience
Apr 20, 2015: Auris Medical Announces Publications Related to AM-101 in Peer-Reviewed Scientific and Medical Journals
Mar 13, 2015: Auris Medical Announces Recently Granted Patent in India for the Treatment of Tinnitus
Mar 11, 2015: Auris Medical to Host Key Opinion Leader Meeting on Tinnitus Treatments on March 13 in New York City
Mar 10, 2015: Auris Medical Announces Completion of Interim Analysis in Post-Acute Tinnitus Stratum of TACTT3 Trial with AM-101
Feb 11, 2015: Auris Medical Announces Recently Granted Patent in China for the Treatment of Tinnitus
Jan 14, 2015: Auris Medical Holding AG Achieves 50% Enrolment Milestone in Post-Acute Tinnitus Stratum of TACTT3 Clinical Trial
Jun 04, 2014: Autifony Therapeutics awarded £2.2 million to progress first-in-classdrug for tinnitus into Phase IIa study
Mar 31, 2014: Published Analysis Confirms Positive Results from Auris Medical's Phase IIb Study with AM-101 in Treatment of Acute Inner Ear Tinnitus
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Tinnitus, H2 2015
Number of Products under Development for Tinnitus - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Comparative Analysis by Unknown Stage Development, H2 2015
Products under Development by Companies, H2 2015
Products under Investigation by Universities/Institutes, H2 2015
Tinnitus - Pipeline by AudioCure Pharma GmbH, H2 2015
Tinnitus - Pipeline by Auris Medical Holding AG, H2 2015
Tinnitus - Pipeline by Flexion Therapeutics, Inc., H2 2015
Tinnitus - Pipeline by Knopp Biosciences LLC, H2 2015
Tinnitus - Pipeline by Merz Pharma GmbH & Co. KgaA, H2 2015
Tinnitus - Pipeline by Otonomy, Inc., H2 2015
Tinnitus - Pipeline by SciFluor Life Sciences, LLC, H2 2015
Tinnitus - Pipeline by Sound Pharmaceuticals, Inc., H2 2015
Tinnitus - Pipeline by Synphora AB, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Tinnitus Therapeutics - Recent Pipeline Updates, H2 2015
Tinnitus - Dormant Projects, H2 2015
List of Figures
Number of Products under Development for Tinnitus, H2 2015
Number of Products under Development for Tinnitus - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Top 10 Targets, H2 2015
Number of Products by Stage and Top 10 Targets, H2 2015
Number of Products by Top 10 Mechanism of Actions, H2 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015
Number of Products by Top 10 Routes of Administration, H2 2015
Number of Products by Stage and Top 10 Routes of Administration, H2 2015
Number of Products by Stage and Top 10 Molecule Types, H2 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report